Literature DB >> 31900692

Blue light therapy to treat candida vaginitis with comparisons of three wavelengths: an in vitro study.

Tianfeng Wang1, Jianfei Dong2, Huancai Yin1, Guoqi Zhang3.   

Abstract

Anti-fungal blue light (ABL) therapies have been widely studied to treat various microbial infections in the literature. The blue light with wavelengths ranging from 400 to 470 nm has been reported to be effective to inhibit various kinds of bacteria and fungi. The existing studies usually report the viability rates of the pathogens under the irradiation of the blue light with different dosage parameters. However, to the best of our knowledge, there is still no work especially focusing on studying the effect of ABL therapies on treating candida vaginitis, where it is important to study the viability of both the Candida albicans (C. albicans) and the human vaginal epithelial cells. It is the purpose of this work to conduct ABL experiments on both of these two cells, analyze the effects, and determine the best ABL wavelength out of three candidates, i.e., 405-nm, 415-nm, and 450-nm wavelength. The viability rates of the C. albicans and the human vaginal epithelial cells irradiated by the three blue LED light sources were measured, whose irradiance (power density) were all set to 50 mW/cm2. The dynamic viability models of the C. albicans and the epithelial cells were built based on the experimental data. Moreover, in this work, we also built a functional relationship between the viability of these two types of cells, by which we further compared the effects of the blue light irradiation on both the C. albicans and vaginal epithelial cells. The experimental data showed that when an approximately 80% inhibiting rate of the C. albicans was achieved, the survival rates of the epithelial cells were 0.6700, 0.7748, and 0.6027, respectively for the treatment by the 405-nm, 415-nm, and 450-nm wavelength light. On the other hand, by simulating the functional relationship between the viability of the two types of cells, the survival rates of the epithelial cells became 0.5783, 0.6898, and 0.1918 respectively using the 405-nm, 415-nm and 450-nm wavelength light, when the C. albicans was completely inhibited. Therefore, both the experimental data and the model simulation results have demonstrated that the 415-nm light has a more effective anti-fungal result with less damage to the epithelial cells than the 405-nm and 450-nm light.

Entities:  

Keywords:  Anti-fungal blue light therapy; Candida albicans; Candida vaginitis; Dynamic viability model; Photobiomodulation

Mesh:

Year:  2020        PMID: 31900692     DOI: 10.1007/s10103-019-02928-9

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  5 in total

Review 1.  Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond?

Authors:  Leon G Leanse; Carolina Dos Anjos; Sana Mushtaq; Tianhong Dai
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

2.  Photoinactivation of Staphylococci with 405 nm Light in a Trachea Model with Saliva Substitute at 37 °C.

Authors:  Tobias Meurle; Johannes Knaus; Agustin Barbano; Katharina Hoenes; Barbara Spellerberg; Martin Hessling
Journal:  Healthcare (Basel)       Date:  2021-03-11

3.  A light-guiding urinary catheter for the inhibition of Proteus mirabilis biofilm formation.

Authors:  Jonathan T Butement; Daniel J Noel; Catherine A Bryant; Sandra A Wilks; Robert W Eason
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

4.  Cataract Development by Exposure to Ultraviolet and Blue Visible Light in Porcine Lenses.

Authors:  Robin Haag; Nicole Sieber; Martin Heßling
Journal:  Medicina (Kaunas)       Date:  2021-05-27       Impact factor: 2.430

5.  Microbial Photoinactivation by Visible Light Results in Limited Loss of Membrane Integrity.

Authors:  Katharina Hoenes; Richard Bauer; Barbara Spellerberg; Martin Hessling
Journal:  Antibiotics (Basel)       Date:  2021-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.